{"id":"https://openalex.org/W2266355686","doi":null,"title":"HIV-associated lipodystrophy, the prevalence, associated factors and metabolic alterations in patients on long term antiretroviral therapy at the Kenyatta National Hospital","display_name":"HIV-associated lipodystrophy, the prevalence, associated factors and metabolic alterations in patients on long term antiretroviral therapy at the Kenyatta National Hospital","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W2266355686","mag":"2266355686"},"language":"en","primary_location":{"id":"pmh:oai:http://erepository.uonbi.ac.ke:11295/6225","doi":null,"is_oa":false,"landing_page_url":"http://erepository.uonbi.ac.ke:8080/handle/123456789/6225","pdf_url":null,"source":{"id":"https://openalex.org/S4306402107","display_name":"University of Nairobi Research Archive (University of Nairobi)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I12859529","host_organization_name":"University of Nairobi","host_organization_lineage":["https://openalex.org/I12859529"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060120040","display_name":"Angela M Awino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Angela M Awino","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5060120040"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-associated-lipodystrophy","display_name":"HIV-associated lipodystrophy","score":0.9919999837875366},{"id":"https://openalex.org/keywords/lipoatrophy","display_name":"lipoatrophy","score":0.8040000200271606},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.9430000185966492},{"id":"https://openalex.org/keywords/duration-of-antiretroviral-therapy","display_name":"antiretroviral therapy duration","score":0.7749999761581421},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.8399999737739563},{"id":"https://openalex.org/keywords/dysglycemia","display_name":"dysglycemia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/metabolic-dysfunction","display_name":"metabolic dysfunction","score":0.7120000123977661},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.7070000171661377},{"id":"https://openalex.org/keywords/prevalence","display_name":"prevalence","score":0.6389999985694885},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.9210000038146973},{"id":"https://openalex.org/keywords/hiv-infected-adults","display_name":"HIV-infected adults","score":0.6320000290870667},{"id":"https://openalex.org/keywords/kenya","display_name":"Kenya","score":0.6740000247955322},{"id":"https://openalex.org/keywords/atherosclerosis-risk","display_name":"atherosclerosis risk","score":0.75},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.5400000214576721}],"concepts":[{"id":"https://openalex.org/C2780941825","wikidata":"https://www.wikidata.org/wiki/Q1538213","display_name":"Lipodystrophy","level":5,"score":0.9479241371154785},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.8248155117034912},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6503321528434753},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5975122451782227},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.45849764347076416},{"id":"https://openalex.org/C61797465","wikidata":"https://www.wikidata.org/wiki/Q1188986","display_name":"Term (time)","level":2,"score":0.44480639696121216},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.353087455034256},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.20207080245018005},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.10103568434715271},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:http://erepository.uonbi.ac.ke:11295/6225","doi":null,"is_oa":false,"landing_page_url":"http://erepository.uonbi.ac.ke:8080/handle/123456789/6225","pdf_url":null,"source":{"id":"https://openalex.org/S4306402107","display_name":"University of Nairobi Research Archive (University of Nairobi)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I12859529","host_organization_name":"University of Nairobi","host_organization_lineage":["https://openalex.org/I12859529"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis"},{"id":"mag:2266355686","doi":null,"is_oa":false,"landing_page_url":"http://erepository.uonbi.ac.ke/handle/11295/6225","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2131246562","https://openalex.org/W7099272545","https://openalex.org/W2139602925","https://openalex.org/W1968348582","https://openalex.org/W393644887","https://openalex.org/W2763897467","https://openalex.org/W2413139163","https://openalex.org/W2339310506","https://openalex.org/W7057965870","https://openalex.org/W2090578116"],"abstract_inverted_index":{"Highly":[0],"active":[1,69,126],"anti-retroviral":[2,70,103,161],"therapy":[3,71,128],"(HAART)":[4],"is":[5],"widely":[6],"available":[7],"to":[8,31,44,428,488,520,547,569,612],"HIV-infected":[9],"individuals.":[10],"Long":[11],"term":[12,588],"complications":[13],"of":[14,54,90,95,102,137,149,154,157,160,171,173,192,220,228,241,250,255,258,271,274,284,295,308,320,346,369,389,410,433,591,603,615,621,625,628,637],"these":[15,203,592],"therapies":[16],"such":[17,165],"as":[18,166,169,190,291,293],"lipodystrophy":[19,55,229,285,315,327,339,349,372,392,413,436,490,522,549,571],"are":[20],"associated":[21,35,59,79,139,267,280,642],"with":[22,60,268,281,348,371,391,412,435,449,552,643],"social":[23],"stigmatization,":[24],"reduced":[25],"self":[26],"esteem":[27],"and":[28,40,46,56,100,106,158,187,199,205,210,217,260,318,350,373,393,414,437,465,503,556,606,630,635],"poor":[29],"adherence":[30],"HAART":[32,275,296,479,498,509,529,538,559,604,638],"while":[33,423],"the":[34,52,57,73,174,200,234,243,269,282],"metabolic":[36,163],"dysregulation":[37,164],"mainly":[38],"dyslipidemia":[39,105,167],"dysglycemia,":[41],"may":[42],"lead":[43],"premature":[45],"accelerated":[47],"atherosclerosis.":[48],"\\nObjective:":[49],"To":[50],"determine":[51],"prevalence":[53,110,227],"factors":[58,80,140,204],"its":[61],"development":[62,270,283],"among":[63],"HIV":[64,91,150,251,622],"sero-positive":[65],"patients":[66,214,309,321,330,347,370,390,411,434,448,474,536,585,593],"on":[67,124,310,322,331,478,497,508,528,537,558,586,595],"highly":[68,125],"~t":[72],"Kenyatta":[74,113],"National":[75,114],"Hospital,":[76,115],"Kenya.":[77],"The":[78,225],"that":[81],"were":[82,215,223,265,365,406,426,455,483,515,543,565,594,610,639],"assessed":[83],"include:":[84],"-":[85,141],"Age,":[86,617],"gender,":[87,143,247,618],"WHO":[88,147,248,619],"stage":[89,148,249,620],"infection":[92,151,252],"at":[93,130,152,253,623],"initiation":[94,153,254,624],"HAART,":[96,155,256,626],"CD4":[97,144,263,633],"count,":[98,146],"type":[99,636],"duration":[101,159],"therapy,":[104,162],"dysglycemia.":[107],"\\nDesign:":[108],"Cross-sectional":[109],"study":[111],"\\nSetting:":[112],"a":[116],"tertiary":[117],"health":[118],"care":[119],"facility":[120],"\\nSubjects:":[121],"Consenting":[122],"adults":[123],"antl-retrovlral":[127],"for":[129,276,297,480,499,530],"least":[131],"six":[132],"months.":[133],"\\nOutcome":[134],"measures:":[135],"Prevalence":[136],"lipodystrophy;":[138],"age,":[142,246],"cell":[145],"combination":[156,600],"defined":[168,189],"presence":[170,191],"any":[172],"following:":[175],"raised":[176,179,185,386],"total":[177,362,563,577],"cholesterol,":[178,181,184],"LDL":[180],"low":[182,407],"HDL":[183,404],"triglycerides;":[186],"dysglycemia":[188],"impaired":[193,459],"fasting":[194,452,460],"glucose":[195],"or":[196,597],"diabetes":[197,466],"mellitus":[198,467],"relationship":[201],"between":[202],"lipodystrophy.":[206,272,616,644],"\\nResults:":[207],"Between":[208],"August":[209],"December":[211],"2007,":[212],"318":[213],"screened":[216],"265":[218],"recruited":[219],"whom":[221],"59.6%":[222],"female.":[224],"overall":[226],"was":[230,233,279,342,385,582],"51.3%.":[231],"Lipoatrophy":[232],"most":[235,261,631],"common":[236,583],"phenotype":[237],"described":[238],"in":[239,344,354,367,376,387,395,408,416,431,439,457,463,468,584],"44%":[240],"all":[242],"patients.":[244],"Patient":[245],"level":[257,627],"baseline":[259],"recent":[262,632],"counts":[264],"not":[266,640],"Use":[273],"18-36":[277,481],"months":[278,301,482,501,514,532],"(p=O.OOO":[286,302,442],"OR":[287,303,357,379,400,419,443],"2.1":[288],"CI":[289,305,359,381,402,421,445],"1.2-3.5)":[290],"well":[292],"use":[294,605],"longer":[298,511],"than":[299,491,512,523,550,572],"36":[300,513],"2.3":[304],"1.2-4.6).":[306],"52.5%":[307],"stavudine":[311,596],"based":[312,324,334,599],"regimen":[313,325,335],"developed":[314],"(p=":[316,328,398],"0.117)":[317],"51.1%":[319],"zidovudine":[323,598],"\\ndeveloped":[326],"0.757).The":[329],"non-stavudine":[332],"non\u00aczidovudine":[333],"also":[336],"had":[337,476,494,506,526,540,561,575],"significant":[338],"(p=O.OOO)":[340],"Dyslipidemia":[341],"found":[343,366,427,456,611],"55.4%":[345],"normal":[351,374,394,415,438,451,553,576],"lipid":[352],"levels":[353,364,375,405,425,609],"36.4%":[355],"(p=0.007":[356],"2.2":[358],"1.3-4.6).":[360],"High":[361],"cholesterol":[363,384,564,578],"57%":[368],"43%":[377],"(p=0.008":[378],"1.94":[380],"1.2-3.2).":[382],"LDL-":[383],"45.9%":[388],"54.1":[396],"%":[397,441],"0.076":[399],"1.5":[401],"0.95-2.6).":[403],"45.2%":[409],"54.8%":[417],"(p=0.257":[418],"1.3":[420],"0.8-2.2)":[422],"triglycerides":[424,542,554],"be":[429,613],"elevated":[430,541,562,607],"65.9%":[432],"34.1":[440],"3.8":[444],"2.3-6.4).":[446],"Among":[447],"lipodystrophy,":[450],"blood":[453,461],"sugars":[454],"68.9%,":[458],"sugar":[462],"25.1%":[464],"5.1%":[469],"(p=0.102).":[470],"On":[471],"multivariate":[472],"analysis,":[473],"who":[475,493,505,525,539,560,574],"been":[477,507,527],"4.4":[484],"times":[485,517,545,567],"more":[486,518],"likely":[487,519,546,568],"have":[489,521],"those":[492,504,524,551,557,573],"\\n-,":[495],"\\nbeen":[496],"6-18":[500,531],"(p